Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Edmondson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Neoplasia (New York, N.Y.)|July 24, 2010
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancersDimitra Dafou, Barbara Grun, John Sinclair, et al.
Gynecologic Oncology|May 28, 2019
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903Linda Mileshkin, Richard Edmondson, Rachel L O'Connell, et al.
Nature Communications|February 15, 2020
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneityLouisa Nelson, Anthony Tighe, Anya Golder, et al.
Journal of Medical Genetics|November 1, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in <i>BRCA1</i> and <i>BRCA2</i>Sue Philpott, Maria Raikou, Ranjit Manchanda, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2024
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024Esther Moss, Alexandra Taylor, Adrian Andreou, et al.
Cancers|January 21, 2023
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian CancerSudha Sundar, Andy Nordin, Jo Morrison, et al.
Nature Genetics|August 15, 2018
Copy number signatures and mutational processes in ovarian carcinomaGeoff Macintyre, Teodora E Goranova, Dilrini De Silva, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Neoplasia (New York, N.Y.)|July 24, 2010
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancersDimitra Dafou, Barbara Grun, John Sinclair, et al.
Gynecologic Oncology|May 28, 2019
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903Linda Mileshkin, Richard Edmondson, Rachel L O'Connell, et al.
Nature Communications|February 15, 2020
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneityLouisa Nelson, Anthony Tighe, Anya Golder, et al.
Journal of Medical Genetics|November 1, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in <i>BRCA1</i> and <i>BRCA2</i>Sue Philpott, Maria Raikou, Ranjit Manchanda, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2024
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024Esther Moss, Alexandra Taylor, Adrian Andreou, et al.
Cancers|January 21, 2023
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian CancerSudha Sundar, Andy Nordin, Jo Morrison, et al.
Nature Genetics|August 15, 2018
Copy number signatures and mutational processes in ovarian carcinomaGeoff Macintyre, Teodora E Goranova, Dilrini De Silva, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
Pageof 3